Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pacific Biosciences of California, Inc. - Common Stock
(NQ:
PACB
)
1.980
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pacific Biosciences of California, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
LifeStance Health Group, Azenta, PacBio, GE HealthCare, and ICU Medical Shares Are Falling, What You Need To Know
October 10, 2025
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.
Via
StockStory
Topics
Economy
Government
World Trade
Why Is PacBio (PACB) Stock Soaring Today
October 08, 2025
Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 9.3% in the morning session after the National Institute on Aging's Long Life Family Study (LLFS) selected its...
Via
StockStory
Applied Materials, GameStop And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
October 03, 2025
Via
Benzinga
Illumina's BioInsight Launch Sparks Optimism, Signals New Era for Genomic Data and AI
October 01, 2025
San Diego, CA – October 1, 2025 – Illumina, Inc. (NASDAQ: ILMN) saw its shares surge by 6.6% today following the announcement and immediate launch of its new business unit, BioInsight. This strategic...
Via
MarketMinute
Topics
Artificial Intelligence
Intellectual Property
AI Takes Center Stage in Biodefense: DARPA's NODES Program Promises to Revolutionize Pandemic and Biowarfare Protection
September 25, 2025
In a groundbreaking leap for global health security, the Defense Advanced Research Projects Agency (DARPA) officially launched its Network of Optimal Dynamic Energy Signatures (NODES) program in July...
Via
MarketMinute
Topics
Artificial Intelligence
3 Small-Cap Stocks with Questionable Fundamentals
September 25, 2025
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...
Via
StockStory
PacBio (PACB) Stock Is Up, What You Need To Know
September 15, 2025
Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 2% in the pre market session after the stock extended its positive momentum as the company partnered with DKSH and...
Via
StockStory
Topics
Artificial Intelligence
Economy
Earnings Scheduled For August 7, 2025
↗
August 07, 2025
Via
Benzinga
Life Sciences Tools & Services Stocks Q2 Teardown: PacBio (NASDAQ:PACB) Vs The Rest
September 14, 2025
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the life sciences tools & services industry, including PacBio (NASDAQ:PACB) and its...
Via
StockStory
Topics
Artificial Intelligence
Economy
Select Medical, Guardant Health, Artivion, PacBio, and Intuitive Surgical Shares Are Falling, What You Need To Know
September 10, 2025
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.
Via
StockStory
Topics
Economy
Stocks
PacBio (PACB) Stock Trades Up, Here Is Why
August 22, 2025
Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 8.3% in the afternoon session after Federal Reserve Chair Jerome Powell opened the door to potential interest rate...
Via
StockStory
Topics
Economy
Stocks
3 Russell 2000 Stocks Walking a Fine Line
August 14, 2025
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher...
Via
StockStory
PacBio (PACB) Shares Skyrocket, What You Need To Know
August 13, 2025
Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 10.4% in the afternoon session after it received favorable reviews from Wall Street, with analysts raising their price...
Via
StockStory
Topics
Artificial Intelligence
The Analyst Verdict: Pacific Biosciences In The Eyes Of 4 Experts
↗
August 11, 2025
Via
Benzinga
PACB Q2 Deep Dive: International Demand, Consumables Growth, and Clinical Adoption Drive Results
August 11, 2025
Genomics company Pacific Biosciences of California (NASDAQ:PACB) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 10.4% year on year to $39.77 million. Its non-GAAP...
Via
StockStory
Topics
World Trade
PacBio (PACB) Stock Trades Up, Here Is Why
August 08, 2025
Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 7.1% in the morning session after the company reported better-than-expected second-quarter 2025 financial results,...
Via
StockStory
PACB Sales Up 11%
↗
August 07, 2025
Via
The Motley Fool
PacBio (NASDAQ:PACB) Delivers Strong Q2 Numbers, Stock Soars
August 07, 2025
Genomics company Pacific Biosciences of California (NASDAQ:PACB) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 10.4% year on year to $39.77 million. Its non-GAAP...
Via
StockStory
Topics
Artificial Intelligence
PacBio (PACB) Q2 Earnings Report Preview: What To Look For
August 05, 2025
Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results this Thursday afternoon. Here’s what to expect.
Via
StockStory
Topics
Artificial Intelligence
World Trade
PacBio, 10x Genomics, QuidelOrtho, STAAR Surgical, and Clover Health Stocks Trade Down, What You Need To Know
July 29, 2025
A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit forecast after reporting a significant surge in medical costs, sending...
Via
StockStory
3 Cash-Burning Stocks Walking a Fine Line
July 28, 2025
Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even...
Via
StockStory
Topics
Bankruptcy
3 Low-Volatility Stocks We Steer Clear Of
July 24, 2025
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Via
StockStory
Why PacBio (PACB) Stock Is Up Today
July 23, 2025
Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 7.4% in the afternoon session after the company announced it had joined the 1000 Genomes Long Read Sequencing Project,...
Via
StockStory
Topics
Government
World Trade
1 Healthcare Stock to Keep an Eye On and 2 to Be Wary Of
July 07, 2025
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...
Via
StockStory
Topics
Stocks
3 Unprofitable Stocks Walking a Fine Line
July 02, 2025
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.
Via
StockStory
Beyond The Numbers: 4 Analysts Discuss Pacific Biosciences Stock
↗
June 25, 2025
Via
Benzinga
3 Stocks Under $10 with Open Questions
June 19, 2025
Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be...
Via
StockStory
The RealReal, Carnival, PacBio, Quest Resource, and Hudson Technologies Shares Are Soaring, What You Need To Know
June 16, 2025
A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +1.5%, S&P 500 +1.0%) as reports pointed to easing tensions between Israel and Iran.
Via
StockStory
Topics
Artificial Intelligence
Economy
Stocks
12 Health Care Stocks Moving In Friday's After-Market Session
↗
June 13, 2025
Via
Benzinga
PACB Q1 Earnings Call: Cost Reductions and Clinical Adoption Offset Market Headwinds
June 10, 2025
Genomics company Pacific Biosciences of California (NASDAQ:PACB) announced better-than-expected revenue in Q1 CY2025, but sales fell by 4.3% year on year to $37.15 million. Its non-GAAP loss of $0.15...
Via
StockStory
Topics
World Trade
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit